Hydroxychloroquine Associated With Lower Glomerular Filtration Rate Decline in Lupus Nephritis
HCQ use was associated with early and long-term benefits on kidney function in LN, including those with CKD stage ≥3. Universal HCQ use should be encouraged in LN patients.
Authors
- Brad C. Astor (ORCID: https://orcid.org/0000-0002-0876-0069)
- Fauzia Osman (ORCID: https://orcid.org/0000-0003-1323-9857)
- Sung Sam Lim (ORCID: https://orcid.org/0000-0003-2361-0787)
- Christie M. Bartels (ORCID: https://orcid.org/0000-0001-6523-0374)
- Brad H. Rovin (ORCID: https://orcid.org/0000-0001-5639-0210)
- Shivani Garg (ORCID: https://orcid.org/0000-0001-7272-2692)
- Lexie Kolton
- Callie Saric (ORCID: https://orcid.org/0009-0003-8034-4873)
- Tripti Singh (ORCID: https://orcid.org/0000-0002-8855-3421)
- Megan Kuik
Institutions
- University of Wisconsin–Madison (US)
- Emory University (US)
- The Ohio State University (US)
Publication Details
- Journal
- Arthritis Care & Research
- Published
- 2025-07-21
- DOI
- https://doi.org/10.1002/acr.25616
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Wisconsin-Madison
- Georgia Clinical and Translational Science Alliance
- National Institutes of Health
- Institute for Clinical and Translational Research, University of Wisconsin, Madison
- School of Medicine and Public Health, University of Wisconsin-Madison
- National Center for Advancing Translational Sciences